February 18, 2021 – Enterprise imaging systems provider Intelerad Medical Systems announced it has acquired Lumedx, a leading provider of healthcare analytics and cardiovascular information systems (CVIS).
On the heels of its recent acquisition of Digisonics Inc., which bolstered the company’s portfolio of solutions for cardiovascular and obstetrics/gynecology. The Lumedx acquisition expands the breadth and reach of Intelerad’s offerings through an expanded suite of solutions, further positioning the company as a leader in the cardiovascular space.
“Healthcare as we know it has forever changed, and more than ever, providers need automated solutions that allow them to focus on what they do best – treating patients and providing improved patient care,” said Mike Lipps, CEO of Intelerad. “Bringing Lumedx into the Intelerad portfolio further enables our team to provide customers with the most comprehensive enterprise imaging platform in the industry.”
As a result of the COVID-19 pandemic, cardiovascular procedures declined significantly as elective and other procedures were put on hold. However, this is expected to dramatically rebound in 2021. Delivering a comprehensive enterprise imaging platform — including robust cardiovascular offerings — is critical as hospitals, health systems and imaging centers seek to consolidate their enterprise imaging requirements on a single-vendor platform, further driving clinical efficiency and patient care.
For more than 25 years, Lumedx helped improve the continuity of care through its cardiovascular data intelligence, cardiovascular information systems (CVIS) and cardiac PACS (CPACS). It also provides analytics for multiple specialties, including orthopedics, neurology, spine and maternal/fetal medicine. The company currently serves more than 650 hospitals and health systems, with proven success in helping customers achieve better patient care.
The company offers cardiology specific solutions for structured reporting, ECG management, inventory, billing, scheduling. It also is a top provider of American College of Cardiology (ACC) NCDR and Society of Thoracic Surgeons (STS) registry software.
“Over the last two and a half decades, Lumedx has been laser-focused on our vision of delivering an end-to-end suite of software and services that improves continuity of care,” said Allyn McAuley, Ph.D., chief executive officer and co-founder of Lumedx. “Joining forces with Intelerad enables us to further achieve this goal, as well as provide customers increased automation that results in greater clinical efficiency and improved patient care.”
The Lumedx acquisition marks Intelerad’s third deal in just six months, extending a period of rapid growth for the company. Financial terms of the acquisition will not be disclosed.
“Since its beginning, Intelerad has played a critical role in building and delivering technology that helps radiologists work more efficiently and maximize the value they add,” said Jean-Baptiste Brian, Intelerad board member and Partner at Hg, which owns Intellerad. “The addition of Lumedx will further enhance Intelerad’s product offerings while enabling the organization to provide new technologies and capabilities.”
Hg is a leading European investor in software and services, focused on backing businesses that change how we all do business. Hg has funds under management of over $30 billion, with an investment team of over 120 professionals, plus a portfolio team of more than 30 operators, providing practical support to help its businesses to realize growth ambitions. Based in London, Munich and New York, Hg has a portfolio of over 30 software and technology businesses, comprising over 35,000 employees across the U.K., U.S. and Europe.
Related Intelerad and Lumedx Content: